Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety
Status: | Recruiting |
---|---|
Conditions: | Insomnia Sleep Studies, Pulmonary, Pulmonary |
Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 21 - 70 |
Updated: | 10/13/2018 |
Start Date: | September 2015 |
End Date: | December 2020 |
Contact: | Jill A Imamura-Ching, RN, BSN |
Email: | Jill.Imamura-Ching@ucsf.edu |
Phone: | (415) 476-3446 |
Magnetic Apnea Prevention (MAGNAP) Device to Treat Obstructive Sleep Apnea: First-In-Human Study of Feasibility and Safety
The purpose of this study is to determine the safety and feasibility of the Magnap magnetic
device in the treatment of obstructive sleep apnea (OSA).
device in the treatment of obstructive sleep apnea (OSA).
Magnap is a magnet-activated treatment for obstructive sleep apnea (OSA) designed to be less
invasive than reconstructive surgery, more tolerable than positive airway pressure, and more
effective than non-invasive therapies for OSA. The Magnap device consists of a
neodymium-iron-boron rare earth magnet with a ferromagnetic directional back-plate encased in
titanium. The device will be implanted surgically on the hyoid bone. Following surgery, the
patient is fitted with a custom, removable external neck accessory containing a second
magnet, which is worn during sleep and prevents airway collapse by attracting the internal
hyoid magnet with sufficient force to keep the airway open .
invasive than reconstructive surgery, more tolerable than positive airway pressure, and more
effective than non-invasive therapies for OSA. The Magnap device consists of a
neodymium-iron-boron rare earth magnet with a ferromagnetic directional back-plate encased in
titanium. The device will be implanted surgically on the hyoid bone. Following surgery, the
patient is fitted with a custom, removable external neck accessory containing a second
magnet, which is worn during sleep and prevents airway collapse by attracting the internal
hyoid magnet with sufficient force to keep the airway open .
Inclusion Criteria:
- Patient is between 21 and ≤70 years of age
- Subject has moderate to severe obstructive sleep apnea (defined as apnea-hypopnea
index of 15-50 events/hour on baseline/screening polysomnogram)
- Subject is intolerant of positive airway pressure therapy (defined as <2 hours of
sleep time with use per night for at least 5 nights per week as measured objectively
by evaluation of continuous positive airway pressure (CPAP) machine memory chip and
interpreted by the study sleep medicine specialist)
- Subject signs and dates a written informed consent form and indicates understanding of
the study procedures and risks
Exclusion Criteria:
- Any evidence that apnea is not caused by base of tongue (i.e., central apnea,
neurologic disorder, retropalatal collapse, nasal obstruction)
- Any condition likely requiring MRI or has a metal implant
- Any factor that, in the surgeon's judgment, would pose a risk to surgery or placement
of a long-term implanted device
- Any factor that, in the surgeon's judgment, would make the subject unlikely to respond
to Magnap treatment
- Congenital anomalies of the larynx, pharynx, or trachea or any other anatomical
abnormality of the head, neck, or chest that would be a contraindication to placement
of the Magnap device and usage of the external device
- There are no exclusion criteria based on gender, race or ethnicity
We found this trial at
1
site
1600 Holloway Avenue
San Francisco, California 94115
San Francisco, California 94115
Phone: 415-476-3446
Click here to add this to my saved trials